GLURESPROBES

"Design, Synthesis and Characterization of ‘Responsive’ MR Contrast Agents Sensitive to Glutamate"

 Coordinatore UNIVERSITY OF DURHAM 

 Organization address address: STOCKTON ROAD THE PALATINE CENTRE
city: DURHAM
postcode: DH1 3LE

contact info
Titolo: Ms.
Nome: Wendy
Cognome: Harle
Email: send email
Telefono: +44 191 33 44639
Fax: +44 191 33 44643

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 0 €
 EC contributo 180˙783 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-IEF-2008
 Funding Scheme MC-IEF
 Anno di inizio 2009
 Periodo (anno-mese-giorno) 2009-06-01   -   2011-05-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITY OF DURHAM

 Organization address address: STOCKTON ROAD THE PALATINE CENTRE
city: DURHAM
postcode: DH1 3LE

contact info
Titolo: Ms.
Nome: Wendy
Cognome: Harle
Email: send email
Telefono: +44 191 33 44639
Fax: +44 191 33 44643

UK (DURHAM) coordinator 180˙783.75

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

glutamate    fmri    mr    neural    responsive    functional    nature    agents    contrast    imaging    pet    brain    human    bold   

 Obiettivo del progetto (Objective)

'Functional Magnetic Resonance Imaging (fMRI) based on Blood-Oxygen-Level-Dependent (BOLD) contrast is currently the mainstay of neuroimaging, whose ever growing applications provide a wealth of information regarding the human brain. The chief advantage of BOLD-fMRI is its non-invasive nature and excellent coverage, but it is limited by poor temporal and spatial resolution, and its surrogate nature. In fact, BOLD imaging, as well as other fMRI methods, are insufficient for a detailed study of the neural networks that underly human or animal cognition. We propose to develop a new approach. The aim is to study exogenous MR contrast agents that are ‘responsive’ biochemical functional markers, capable of detecting neuronal activity in real time and translating it into changes of MR contrast. Our objective is to develop glutamate responsive contrast agents to image changes in different parts of the brain upon neural activation. We also aim to improve the sensitivity of these bio-responsive agents by introducing additional modality for Positron Emission Tomography (PET) in the molecules. Initially, novel selective classes of specific, efficacious and optimized Glutamate receptors antagonists along with contrast enhancing macrocyclic lanthanide-chelates, will be developed. The initiatives in chemistry include both tailored organic synthesis and complexation of non-toxic metallo-pharmaceuticals, whose ligand design is dictated by the desired structure-activity relationship. Glutamate receptor sensitive specific extracellular responsive contrast agents will be considered. Every agent will be characterized by different chemical methods and finally evaluated by means of in vitro MR/PET measurements in simulated physiological conditions.'

Altri progetti dello stesso programma (FP7-PEOPLE)

CONSYDER (2013)

CONvective SYstems DEtection and analysis using Radio occultations

Read More  

AC FOR PKU TREATMENT (2012)

Artificial Cells for Enzyme Replacement Therapy for Phenylketonuria

Read More  

COCAINE GENE NETWORK (2014)

Molecular Analysis of Gene Regulatory Networks Underlying the Persistence of Drug Addiction

Read More